Today we will take a closer look at Siemens Healthineers stock.
The Siemens subsidiary, which has been trading on the stock market since 2018, has placed fresh shares with institutional investors. The aim is to use the fresh capital to finance the purchase of Varian. This is the second capital increase in the billion euro range within the last seven months. A total of EUR 2.34 billion was raised from institutional investors. The largest investor is the Qatari sovereign wealth fund, QIA, with 380 million euros.
The stock price of the Siemens subsidiary has performed very solidly since the IPO in 2018.
Currently, the price is at 46.76 euros and thus only just below the all-time high from February at 49.99 euros. The next resistance level must be exceeded at 47.76 euros.
